M
BMY icon

Mirova’s Bristol-Myers Squibb BMY Stock Holding History

Mirova’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,134
Closed -$412K – 96
2025
Q3 		$412K Buy
9,134
+4,459
+95% +$208K 0.06% 97
2025
Q2 		$216K Sell
4,675
-10,130
-68% -$497K 0.03% 111
2025
Q1 		$903K Buy
+14,805
New +$863K 0.16% 80
2024
Q2 		– Sell
-4,452
Closed -$241K – 128
2024
Q1 		$241K Hold
4,452
– – 0.04% 102
2023
Q4 		$228K Sell
4,452
-272
-6% -$14.3K 0.05% 79
2023
Q3 		$274K Sell
4,724
-7,529
-61% -$461K 0.06% 77
2023
Q2 		$784K Sell
12,253
-13,030
-52% -$874K 0.14% 72
2023
Q1 		$1.75M Sell
25,283
-20,304
-45% -$1.43M 0.25% 65
2022
Q4 		$3.28M Buy
45,587
+10,854
+31% +$818K 0.51% 39
2022
Q3 		$2.47M Sell
34,733
-15,435
-31% -$1.12M 0.42% 41
2022
Q2 		$3.86M Sell
50,168
-11,214
-18% -$854K 0.55% 30
2022
Q1 		$4.48M Sell
61,382
-1,391
-2% -$93.4K 0.6% 25
2021
Q4 		$3.91M Buy
62,773
+48,296
+334% +$2.83M 0.47% 29
2021
Q3 		$856K Buy
14,477
+1,327
+10% +$87.4K 0.11% 97
2021
Q2 		$878K Buy
13,150
+844
+7% +$55K 0.11% 81
2021
Q1 		$776K Buy
12,306
+1,673
+16% +$104K 0.09% 84
2020
Q4 		$659K Buy
10,633
+8,644
+435% +$532K 0.08% 80
2020
Q3 		$120K Sell
1,989
-676
-25% -$40.7K 0.02% 86
2020
Q2 		$157K Sell
2,665
-59
-2% -$3.53K 0.04% 69
2020
Q1 		$152K Sell
2,724
-1,192
-30% -$72.9K 0.06% 65
2019
Q4 		$251K Buy
3,916
+1,898
+94% +$109K 0.09% 72
2019
Q3 		$102K Buy
2,018
+183
+10% +$8.6K 0.01% 94
2019
Q2 		$83K Buy
+1,835
New +$85.5K 0.01% 94

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mirova's BMY Position: Q4 2025 in Review

Mirova sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 9,134 shares — an estimated $412K sold.

Mirova first reported a position in BMY in Q2 2019 and held it in 23 quarters. The position peaked at $4.48M in Q1 2022. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Mirova reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Mirova sold 9,134 Bristol-Myers Squibb shares in Q4 2025, an estimated $412K.
  • Mirova first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 23 quarters.
  • Mirova's Bristol-Myers Squibb position peaked at $4.48M in Q1 2022.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Mirova's 13F filing for Q4 2025, filed 13 Feb 2026.